Catalyst Wire Dossier Catalyst Wire Dossier

Abraxane (albumin-bound paclitaxel)

paclitaxel protein-bound albumin · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Abraxane (albumin-bound paclitaxel), covering 2024-07-19 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma [Phase 1, Phase 2]

See pricing